Fair Value Calculator Fair Value Calculator
EN DE

ISHITADR (ISHITADR) Fair Value & Analysis

IN · Market cap ₹219M

I ISHITADR ISHITADR · BSE
Price₹73.10
Fair Value₹44.26
Upside-39.5%
Quality58/100
Watch ISHITADR for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹33.19 – ₹55.32

Fair value as of: Jul 5, 2026

From 21 valuation models · updated today

Share price −6.3% over the past month.

Price vs Fair Value (12 months)

₹84.11 ₹67.60 Fair Value ₹44.26 Jul 2025 Jul 2026

12‑month range ₹67.60 – ₹84.11 · fair‑value band ₹33.19 – ₹55.32 · the ₹73.10 price screens above the ₹44.26 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ISHITADR (ISHITADR) currently trades at ₹73.10, while our model-based Fair Value estimate is ₹44.26 — implying the stock looks roughly 39.5% overvalued today. We read business quality at 58/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, ISHITADR generated revenue of ₹147M at a net margin of 5.3%. Revenue declined 28.3% year over year. It earns a return on equity of 7.0%. Net debt stands at ₹33.3M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹33.19 (bear case) to ₹55.32 (bull case); at ₹73.10, the current price sits above that range. The share trades about 20% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹147M
Revenue growth (YoY) -28.3%
Net margin 5.3%
Return on equity 7.0%
Free cash flow ₹20.7M FY2026
P/E ratio 28.1
More key figures
Operating margin 9.0%
EPS (TTM) ₹2.60
EPS growth (YoY) -38.3%
Net debt ₹33.3M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

ISHITADR reported revenue of ₹147M in FY2026 versus ₹141M in FY2022, a compound +1.0%/yr. Reported net income was ₹7.8M in FY2026, compounding −0.8%/yr from FY2022.

Revenue +1.0%/yr
FY22 ₹141M
FY23 ₹121M
FY24 ₹152M
FY25 ₹150M
FY26 ₹147M
Net income −0.8%/yr
FY22 ₹8.0M
FY23 ₹5.8M
FY24 ₹7.5M
FY25 ₹8.7M
FY26 ₹7.8M

Is ISHITADR fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "ISHITADR Fair Value". https://www.fairvalue-calculator.com/stock/ISHITADR

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is ISHITADR (ISHITADR) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹44.26 versus a price of ₹73.10 — about −39% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ISHITADR?
Our model-based fair value for ISHITADR is ₹44.26 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹73.10.
What is the quality score of ISHITADR?
ISHITADR has a Quality Score of 58/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of ISHITADR (ISHITADR)?
ISHITADR reported trailing-twelve-month revenue of about ₹147M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of ISHITADR?
The net profit margin of ISHITADR is about 5.3%, meaning it keeps roughly 5.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.